Anti-IL-1 inhibits the activity of interleukin-1 (IL-1), which plays a crucial role in inflammation via activation of canonical NF-κB signaling and is associated with various autoimmune and inflammatory conditions such as rheumatoid arthritis, gout, and certain skin diseases. Here, IL1B is linked to gout.